Insomnia is estimated to affect 70% of Australians and most taking over-the-counter sleep medications.
A sleep study undertaken at University of Western Australia (UWA) Centre for Sleep Science by Professor Peter Eastwood has shown promising resulting’s as an alternative to taking traditional sleeping medications, such as benzodiazepines for insomniacs.
Study Conclusion: Two-weeks of nightly sublingual administration of a cannabinoid extract (ZTL-101) is well tolerated and improves insomnia symptoms and sleep quality in individuals with chronic insomnia symptoms.
Find out more about the study here: https://pubmed.ncbi.nlm.nih.gov/34115851/